Sanofi · 3 months ago
UX Design Lead
Sanofi is an innovative global healthcare company committed to improving people's lives through science. They are seeking a UX Design Lead to architect AI-powered experiences that simplify complex scientific workflows and drive innovation, collaborating with a diverse team to enhance user-centric design across their digital solutions.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Lead the development and implementation of user-centric design strategies across Sanofi’s R&D digital solutions
Architect end-to-end user journeys that integrate SaaS platforms into a cohesive digital ecosystem
Translate complex scientific workflows into intuitive, actionable design solutions
Collaborate with Product, Engineering, and CX Strategy teams to deliver scalable, unified experiences
Guide all phases of UX design: research synthesis, ideation, prototyping, specification, and implementation
Define and maintain interaction and UI design standards and patterns across platforms
Advocate for design excellence and consistency across teams and stakeholder groups
Drive continuous improvement in design processes, tools, and operational execution
Lead design reviews and mentor freelance and junior designers
Qualification
Required
Proven experience (6+ years) in creating and executing design strategies for digital products
Expert in interaction design, human-centered design, and design systems
Strong storytelling and communication skills with the ability to influence stakeholders
Proficient in design tools such as Figma, Sketch, InVision, Adobe Creative Suite
Familiarity with web technologies (HTML, CSS, JavaScript) and platform guidelines (iOS, Android)
Experience working in Agile or Lean environments
Bachelor's degree required
Preferred
Master's degree in a relevant field is a plus
Experience in pharma or health tech is a plus
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Recent News
2026-01-16
Company data provided by crunchbase